Comparative Pharmacology
Head-to-head clinical analysis: ARIDOL KIT versus XYLOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ARIDOL KIT versus XYLOSE.
ARIDOL KIT vs XYLOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol, a sugar alcohol, acts as an osmotic diuretic and osmotic agent. It increases plasma osmolality, drawing water from tissues into the bloodstream and enhancing urinary excretion. In the respiratory tract, it is used as a bronchial challenge agent to induce bronchoconstriction in patients with asthma by increasing airway osmolality and triggering mast cell mediator release.
Xylose is a pentose sugar that is absorbed in the small intestine via passive diffusion and active transport. It is used to assess intestinal mucosal integrity; its absorption reflects the function of the enterocytes. After absorption, it is not metabolized and is excreted unchanged in urine, making it a marker for intestinal absorption and renal function.
Aridol (mannitol) is administered via inhalation as a dry powder for bronchial challenge testing. The standard adult dose is a single capsule (25 mg) inhaled using the Aridol inhaler device, with doses escalated as per protocol (e.g., 5, 10, 20, 40 mg cumulative) until a 15% fall in FEV1 is achieved or maximum cumulative dose of 160 mg is reached.
Adults: 25 g orally in 500 mL water, administered as a single dose for D-xylose absorption test.
None Documented
None Documented
The terminal elimination half-life of mannitol is approximately 100 minutes (1.7 hours) in patients with normal renal function. This may be prolonged up to 36 hours in patients with renal impairment, necessitating dose adjustment.
Terminal elimination half-life: 1.2-2.5 hours in adults with normal renal function; prolonged in renal impairment (up to 10 hours).
Mannitol (the active ingredient in Aridol Kit) is primarily excreted unchanged in the urine via glomerular filtration, with approximately 80-90% of an intravenous dose eliminated within 24 hours. Less than 10% is metabolized in the liver, and negligible amounts are eliminated in feces or bile.
Renal: approximately 85-90% eliminated unchanged in urine; biliary/fecal: negligible (<5%).
Category C
Category C
Diagnostic Agent
Diagnostic Agent